Cargando…
Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma
Glioblastoma (GB) is the most common and devastating form of brain cancer. Despite conventional treatments, progression or recurrences are systematic. In recent years, immunotherapies have emerged as an effective treatment in a number of cancers, leaving the question of their usefulness also faced w...
Autores principales: | Grégoire, Hélène, Roncali, Loris, Rousseau, Audrey, Chérel, Michel, Delneste, Yves, Jeannin, Pascale, Hindré, François, Garcion, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158850/ https://www.ncbi.nlm.nih.gov/pubmed/32322199 http://dx.doi.org/10.3389/fphar.2020.00368 |
Ejemplares similares
-
Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells
por: Séhédic, Delphine, et al.
Publicado: (2021) -
Potential for Nuclear Medicine Therapy for Glioblastoma Treatment
por: Bailly, Clément, et al.
Publicado: (2019) -
A role for ceruloplasmin in the control of human glioblastoma cell responses to radiation
por: Roy, Charlotte, et al.
Publicado: (2022) -
Antitumor strategies targeting macrophages: the importance of considering the differences in differentiation/polarization processes between human and mouse macrophages
por: Monnier, Marine, et al.
Publicado: (2022) -
Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives
por: Lepareur, Nicolas, et al.
Publicado: (2019)